PSTV - PLUS THERAPEUTICS, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.71 -0.03 (-4.96%)	---	-0.01 (-2.02%)	-0.01 (-1.46%)	0.01 (0.72%)	-0.03 (-4.58%)	-0.01 (-1.76%)	-0.01 (-1.76%)

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Market Period: Closed

Earnings & Ratios

Basic EPS:: 0.02
Diluted EPS:: -0.01
Basic P/E:: 33.5
Diluted P/E:: -67.0
RSI(14) 1m:: 50.0
VWAP:: 0.67
RVol:

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.67 -0.01 (-1.29%)	Oct 15 19:12
1m	Price increase 1m	0.69 +0.01 (+1.19%)	Oct 15 17:40
1m	Price increase 1m	0.68 +0.01 (+1.46%)	Oct 15 16:26